ALK and non-small cell lung carcinoma: Yang et al. highlighted that silencing HOTAIR inhibited resistance to anti-Anaplastic kinase lymphoma (ALK) and ROS Proto-Oncogene 1 (ROS1) inhibitor, Crizotinib, suppressing tumour progression by promoting apoptosis in NSCLC cells.